Antibiotice S.A. (BVB: ATB)

Antibiotice Income Statement

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	648.24	614.16	497.5	376.76	346.78	394.37
Other Revenue	2.46	1.12	7.5	2.07	0.45	0.78
Revenue	650.7	615.29	505	378.83	347.22	395.15
Revenue Growth (YoY)	13.75%	21.84%	33.31%	9.10%	-12.13%	7.17%
Cost of Revenue	240.28	230.09	187.45	146.97	109.56	143.06
Gross Profit	410.42	385.19	317.55	231.86	237.66	252.09
Selling, General & Admin	163.75	161.69	130.53	125.92	118.01	108.39
Other Operating Expenses	108.83	98.2	91.94	47.57	60.43	82.55
Operating Expenses	308.61	287.77	244.73	197.61	200.24	212.35
Operating Income	101.81	97.42	72.81	34.25	37.42	39.74
Interest Expense	-4.01	-4.15	-3.59	-3.52	-4.93	-4.69
Interest & Investment Income	0	0	0	0	0	0.01
Currency Exchange Gain (Loss)	0.46	-0.95	-0.8	-0.22	-3.72	0.11
Other Non Operating Income (Expenses)	0	0.08	-0.18	-0.21	-0.44	0.02
EBT Excluding Unusual Items	98.27	92.42	68.25	30.3	28.33	35.18
Gain (Loss) on Sale of Assets	0	0	0.1	-	-	-
Asset Writedown	-0.9	-0.9	-3.04	-	-	-
Pretax Income	97.38	91.52	65.31	30.3	28.33	35.18
Income Tax Expense	4.1	10.44	13.84	0.36	1.94	4.36
Net Income	93.28	81.09	51.47	29.94	26.39	30.82
Net Income to Common	93.28	81.09	51.47	29.94	26.39	30.82
Net Income Growth	17.34%	57.54%	71.92%	13.46%	-14.39%	-10.15%
Shares Outstanding (Basic)	671	671	671	671	671	671
Shares Outstanding (Diluted)	671	671	671	671	671	671
Shares Change (YoY)	0.03%	-	-	-	-	-
EPS (Basic)	0.14	0.12	0.08	0.04	0.04	0.05
EPS (Diluted)	0.14	0.12	0.08	0.04	0.04	0.05
EPS Growth	17.30%	57.54%	71.92%	13.46%	-14.39%	-10.15%
Free Cash Flow	45.2	39.43	78.09	15.39	46.06	-48.56
Free Cash Flow Per Share	0.07	0.06	0.12	0.02	0.07	-0.07
Dividend Per Share	0.083	0.083	0.008	0.003	0.003	0.030
Dividend Growth	946.74%	946.74%	147.72%	-3.27%	-88.94%	199.04%
Gross Margin	63.07%	62.60%	62.88%	61.20%	68.45%	63.80%
Operating Margin	15.65%	15.83%	14.42%	9.04%	10.78%	10.06%
Profit Margin	14.34%	13.18%	10.19%	7.90%	7.60%	7.80%
Free Cash Flow Margin	6.95%	6.41%	15.46%	4.06%	13.27%	-12.29%
EBITDA	137.89	125.35	95.38	58.68	59.52	61.46
EBITDA Margin	21.19%	20.37%	18.89%	15.49%	17.14%	15.55%
D&A For EBITDA	36.08	27.93	22.57	24.43	22.1	21.72
EBIT	101.81	97.42	72.81	34.25	37.42	39.74
EBIT Margin	15.65%	15.83%	14.42%	9.04%	10.78%	10.06%
Effective Tax Rate	4.21%	11.40%	21.19%	1.20%	6.85%	12.38%
Advertising Expenses	-	-	-	11.01	8.69	7.74

Source: S&P Capital IQ. Standard template. Financial Sources.